Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
MustGrow Biologics ( (TSE:MGRO) ) has issued an announcement.
MustGrow Biologics has signed a five-year exclusive distribution agreement with Adjuvants Plus Inc. to distribute Adjuvants’ biological product line across Canada, marking a significant step in promoting sustainable agricultural solutions. This partnership enhances MustGrow’s product portfolio with Adjuvants’ patented microbial technology and aims to support sustainable crop management, particularly in major Canadian crops, reinforcing its position as a leader in biological agriculture.
More about MustGrow Biologics
MustGrow Biologics Corp. is a leading provider of biological and regenerative agriculture solutions, focusing on enhancing crop productivity while preserving soil health. The company recently expanded its operations through the acquisition of NexusBioAg, a Canadian sales and distribution division.
YTD Price Performance: 5.88%
Average Trading Volume: 1,694
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $47.91M
Learn more about MGRO stock on TipRanks’ Stock Analysis page.